According to Cryo-Cell's latest financial reports the company's current revenue (TTM) is $31.37 M. In 2022 the company made a revenue of $30.33 M an increase over the years 2021 revenue that were of $28.88 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $31.34 M | 3.32% |
2022 | $30.33 M | 5.03% |
2021 | $28.88 M | -7.26% |
2020 | $31.14 M | -2.1% |
2019 | $31.81 M | 8.89% |
2018 | $29.21 M | 15.1% |
2017 | $25.38 M | 9.76% |
2016 | $23.12 M | 9.66% |
2015 | $21.09 M | 4.79% |
2014 | $20.12 M | 5.96% |
2013 | $18.99 M | 5.7% |
2012 | $17.96 M | 0.29% |
2011 | $17.91 M | 0.98% |
2010 | $17.74 M | 1.1% |
2009 | $17.55 M | 1.58% |
2008 | $17.27 M | -1.04% |
2007 | $17.46 M | 1.63% |
2006 | $17.18 M | 18.88% |
2005 | $14.45 M | 18.35% |
2004 | $12.21 M | 61.74% |
2003 | $7.54 M | 10.48% |
2002 | $6.83 M | 20.98% |
2001 | $5.64 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Omnicell
OMCL | $1.14 B | 3,556.54% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $0.19 B | 517.95% | ๐ญ๐ฐ Hong Kong |
CorVel Corporation
CRVL | $0.77 B | 2,365.68% | ๐บ๐ธ USA |